Prospective Evalulation of Artificial Intelligence-assisted Monitoring of Effective Withdrawal Time Versus Standard Withdrawal Time on Adenoma Detected Per Colonoscopy
1 other identifier
observational
198
1 country
1
Brief Summary
The goal of this observational study is to assess the correlation between the artificial intelligence (AI) derived effective withdrawal time (EWT) during colonoscopy and endoscopists' adenoma per colonoscopy (APC), polyp per colonoscopy(PPC), adenoma detection rate (ADR), polyp detection rate (PDR) and during colonoscopy for each endoscopists. The association between the AI derived EWT with all colonoscopy outcomes during the prospective colonoscopy series would also be determined. The colonoscopy video of participants will be monitored by the AI. The result will be compared with standard withdrawal time (SWT).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Nov 2023
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 1, 2023
CompletedFirst Submitted
Initial submission to the registry
March 22, 2024
CompletedFirst Posted
Study publicly available on registry
April 3, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 30, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
January 31, 2025
CompletedJune 11, 2025
November 1, 2023
11 months
March 22, 2024
June 5, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Adenoma per colonoscopy of the endoscopists
Adenoma per colonoscopy of the endoscopists
During the colonoscopy
Secondary Outcomes (5)
Adenoma detection rate of the endoscopists
During that colonoscopy
Polyp detection rate of the endoscopists
During that colonoscopy
Polyp per colonoscopy of the endoscopists
During colonoscopy
Serrated Lesion per Colonoscopy of the endoscopist
During the colonoscopy
Serrated Lesion Detection Rate of the endoscopist
During colonoscopy
Study Arms (1)
AI group
AI monitoring of effective withdrawal time
Interventions
Eligibility Criteria
All patient will be recruited in Queen Mary Hospital, Hong Kong, China
You may qualify if:
- All adult patients, aged 40 or above, undergoing outpatient colonoscopy will be recruited
You may not qualify if:
- history of inflammatory bowel disease
- history of colorectal cancer
- previous bowel resection (apart from appendectomy)
- Peutz-Jeghers syndrome, familial adenomatous polyposis or other polyposis syndromes
- bleeding tendency or severe comorbid illnesses for which polypectomy is considered unsafe.
- Cecum could not be intubated for various reasons
- Poor bowel preparation with Boston Bowel Preparation Scale (BBPS) \< 6
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Queen Mary Hospital, the University of Hong Kong
Hong Kong, Hong Kong
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Thomas Ka-Luen Lui
The University of Hong Kong
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 22, 2024
First Posted
April 3, 2024
Study Start
November 1, 2023
Primary Completion
September 30, 2024
Study Completion
January 31, 2025
Last Updated
June 11, 2025
Record last verified: 2023-11